Allostery in disease and in drug discovery

Ruth Nussinov*, Chung Jung Tsai

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

543 Scopus citations

Abstract

Allostery is largely associated with conformational and functional transitions in individual proteins. This concept can be extended to consider the impact of conformational perturbations on cellular function and disease states. Here, we clarify the concept of allostery and how it controls physiological activities. We focus on the challenging questions of how allostery can both cause disease and contribute to development of new therapeutics. We aim to increase the awareness of the linkage between disease symptoms on the cellular level and specific aberrant allosteric actions on the molecular level and to emphasize the potential of allosteric drugs in innovative therapies.

Original languageEnglish
Pages (from-to)293-305
Number of pages13
JournalCell
Volume153
Issue number2
DOIs
StatePublished - 11 Apr 2013

Funding

FundersFunder number
National Institutes of HealthHHSN261200800001E
National Cancer InstituteZIABC010440

    Fingerprint

    Dive into the research topics of 'Allostery in disease and in drug discovery'. Together they form a unique fingerprint.

    Cite this